Best of the Week
Most Popular
1.Canada Real Estate Bubble - Harry_Dent
2.UK House Prices ‘On Brink’ Of Massive 40% Collapse - GoldCore
3.Best Cash ISA for Soaring Inflation, Kent Reliance Illustrates the Great ISA Rip Off - Nadeem_Walayat
4.Understanding true money, Pound Sterling must make another historic low, Euro and Gold outlook! - Marc_Horn
5.5 Maps That Explain The Modern Middle East - GEORGE FRIEDMAN
6.Gold Back With A Vengeance As Bitcoin Bubble Bursts - OilPrice_Com
7.Gold Summer Doldrums - Zeal_LLC
8.Crude Oil Trade & Nasdaq QQQ Update - Plunger
9.Gold And Silver – Why No Rally? Lies, Lies, And More Lies - Michael_Noonan
10.UK Election 2017 Disaster, Fake BrExit Chaos, Forecasting Lessons for Next Time - Nadeem_Walayat
Last 7 days
The Fed May Show Trump No Love - 20th Jul 17
The 3 Best Asset Classes To Brace Your Portfolio For The Next Financial Crisis - 20th Jul 17
Gold Stocks and Bonds - Preparing for THE Bottom - 20th Jul 17
Millennials Can Punt On Bitcoin, Own Safe Haven Gold For Long Term - 20th Jul 17
Trump Has Found A Loophole To Rewrite Trade Agreements Without Anyone’s Permission - 20th Jul 17
Basic Materials and Commodities Analysis and Trend Forecasts - 20th Jul 17
Bitcoin PullBack Is Over (For Now): Cryptocurrencies Gain Nearly A 50% In Last 48 Hours - 19th Jul 17
AAPL's 6% June slide - When Prices Are Falling, TWO Numbers Matter Most - 19th Jul 17
Discover Why A Major American Revolution Is Brewing - 19th Jul 17
iGaming – Stock Prices - 19th Jul 17
The Socionomic Theory of Finance By Robert Prechter - Book Review - 18th Jul 17
Ethereum Versus Bitcoin – Which Cryptocurrency Will Win The War? - 18th Jul 17
Accepting a Society of Government Tyranny - 18th Jul 17
Gold Cheaper Than Buying Greek Villas in 2012 - 18th Jul 17
Why & How to Hedge the Growing Risks of Holding Stocks - 18th Jul 17
Relocation: Everything You Need to do for a Smooth Transition Abroad - 17th Jul 17
A Former Lehman Brothers Trader: It’s Time To Buy Brick And Mortar Retailers - 17th Jul 17
Bank Of England Warns “Bigger Systemic Risk” Now Than 2008 - 17th Jul 17
Bitcoin Price “Deja Vu” Corrective Sequence - 17th Jul 17
Charting New Low in Speculation in Gold and Silver Markets - 17th Jul 17
Bitcoin Crash - Is This The End of Cryptocurrencies? - 17th Jul 17
The Fed's Inflation Nightmare Scenario - 17th Jul 17
Billionaire Investors Backing A Marijuana Boom In 2017 - 17th Jul 17
Perfect Storm - This Fourth Turning has Over a Decade of Continuous Storms to Come - 17th Jul 17
Gold and Silver Biggest Opportunity Since Late 2015, Last Chance at These Prices - 17th Jul 17
Stock Market More to Go - 17th Jul 17
Emerging Markets & Basic Materials Stocks Breaking Out Together - 16th Jul 17
Stock Market SPX Uptrending Again After Microscopic Correction - 15th Jul 17
Global Currency Reserve At Risk - 14th Jul 17
Picking Great Gold Stocks - 14th Jul 17
BBC Tree Expert's Verdict on Sheffield Amey / Labour City Council Tree Felling's - 14th Jul 17
SPX Cycles, Fed Funds and Gold - 14th Jul 17
Should Platinum Be More Expensive Than Gold? - 14th Jul 17
What's Next for US Dollar, Stocks, Bonds and Gold? - 13th Jul 17
India Gold Imports Surge To 5 Year High – 220 Tons In May Alone - 13th Jul 17
Gold and Silver: Your Stomach Is Probably Wrenching Right Now - 13th Jul 17
Gold Industry Is In A Deep State Of Dysfunction, Delusion And Denial - 13th Jul 17
Cryptocurrency Bloodbath! Sell Everything We Were Totally Wrong! - 12th Jul 17
Gold to Silver Ratio - Preparing for THE Bottom - 12th Jul 17
Iran and North Korea: Brothers in Nuclear Arms - 12th Jul 17
Down Dollar Down: Time for "UP"? - 12th Jul 17
Most Tech People Are Too Young To Remember That Silicon Valley Hasn’t Had A Real Crisis In 17 Years - 11th Jul 17
Stock Market Rally May be Over - 11th Jul 17
Silver Price Plunge Is Nearing Completion - 11th Jul 17
Soaring Global Demand for Lithium Presents Triple-Digit Profit Scenario - 11th Jul 17
Gold Price Outlook Increasingly Bullish - 11th Jul 17
Sheffield Street Tree Protestors / Campaigners vs Amey Labour City Council 2017 - 11th Jul 17

Market Oracle FREE Newsletter

3 Videos + 8 Charts = Opportunities You Need to See - Free

Billionaire Investors Backing A Marijuana Boom In 2017

Commodities / Cannabis Jul 17, 2017 - 01:57 PM GMT

By: OilPrice_Com

Commodities

The biggest multi-decade opportunity for investors right now is the Canadian government’s legislation to legalize recreational marijuana by this time next year—and the first companies to win government approval will the high-risers.

In a sector that’s already seen stocks bust the borders with 1000% spikes, there is one company that currently has 2 of the only 50 licenses to cultivate in Canada, positioning itself to burst out of the gates as new legislation creates a multi-billion-dollar industry over night.


With one of the largest land packages to build cultivation facilities and 2 current licensed facilities located in two provinces in Canada, small-cap Invictus MD (TSX:IMH.VOTC:IVITF) is set to rise.

It’s already the first licensed medical marijuana company to pay a dividend to shareholders, and with its strains reaching into everything from pain management, cancer, epilepsy, anxiety and – most lucratively of all—recreation, the sky is the limit here.

We’re now just shy of a year away from the start date of legal recreational use, and there are already predictions of a looming supply shortage.

Financial Post reports... there will soon be 3.8 million recreational users... But the market is only currently equipped to handle 150,000 medical marijuana patients.

The industry is scrambling to add growing capacity once the legal barriers are tossed aside. 

Deloitte estimates this industry could be worth a whopping $22.6 billion annually. That’s more than the combined sales of beer, wine and spirits.

Right out of the gate, Invictus MD, owner of two of just 50 licenses, has demonstrated that it will lead the way. The company holds $30 million in cash and is already generating dividends—a feat unheard of in the pot industry.

That’s why it’s called ‘Canada’s Cannabis Company’—it’s already cemented market share for medical marijuana use, and now it’s one of the first in and ready to fill the supply gap for a massive recreational push to supply 3.65 million new users.   

Here are 5 Reasons to keep a close eye on Invictus MD (TSX:IMH.VOTC:IVITF):

#1 The Minting of the Next North American Billionaires

When you suddenly legalize a product that’s already got a massive market under the table, you mint billionaires overnight. Just like it did at five o’clock on December 5, 1933—the moment Prohibition ended, and a billion-dollar industry (even then) was reborn.

It’s already happening: The shares of the medical marijuana producers more than tripled last year, just at the prospects.

• AXIM Biotechnologies (NASDAQOTH:AXIM): exploded 1,720 percent
• Corbus Pharmaceuticals (
NASDAQ:CRBP) was up 431 percent
• Aphria (
NASDAQOTH:APHQF) grew 381 percent
• Aurora Cannabis (
NASDAQOTH:ACBFF) was up 299 percent
• Canopy Growth Corp. (
NASDAQOTH:TWMJF) up 259 percent
• Medical Marijuana (
NASDAQOTH:MJNA) up 254 percent
• GW Pharmaceuticals (
NASDAQ:GWPH) was up 64 percent

The smart money is investing too. Tribeca Investment Partners, a boutique fund manager, used bets on marijuana companies to help generate a 145 percent return over the year, according to Fortune magazine and Bloomberg. Nearly US$20 million of its investment gains in 2016 came from marijuana stocks, including Aurora Cannabis and Canopy Growth.

Then, in early April, Canada launched its first marijuana exchange-traded fund (ETF), giving investors diverse exposure to this tantalizing sector. The Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ) launched on the 4th of April on the Toronto Stock Exchange with 11 Canadian-listed stocks and four U.S.-listed stocks.

On 23 June, Invictus was included in the ETF.

The frenzy surrounding Canada’s marijuana market is palpable, and will be even more frenzied on 1 July 2018.

And Invictus is way ahead of this game: It’s already got a license to produce in this multi-billion-dollar market.  

#2 A Pot Pipeline Going in Every Direction

Invictus MD (TSX:IMH.V; OTC:IVITF) has multiple projects in its Canadian investment pipeline—all of them bolstered by some extremely savvy acquisitions.

The company’s dream team targets small- and mid-size companies with significant growth potential and directs their strategies towards profitability.

They’ve made some game-changing acquisitions at just the right time; yet, their valuation is far below their peers, making Invictus a real entry point into this lucrative market if you’re looking for outsized gains.  

The company owns over 33 percent of AB Laboratories Inc., which received its cultivation license last October. The catalysts here are mounting, with the sales license expected in Q2. This facility has a capacity for 1,000 kilograms, with active expansion plans underway.

In May, Invictus also closed its acquisition of 100 acres with AB Ventures Inc., and is targeting production here of 25,000 kilograms by 2020.

In Alberta, Acreage Pharms received its license to cultivate under ACMPR and has a purpose built 7,000 square foot facility and a 30,000-square-foot expansion plan. Invictus MD currently owns 100 percent of this license.

It’s a brilliant set-up for a small-cap company with CAD$30 million in cash and 78 million basic outstanding shares.

#3 Pot Dividends? The Impossible Because Reality

Invictus MD (TSX:IMH.V; OTC:IVITF)—made history in December by giving shareholders something they never expected to see in the marijuana industry in this decade: dividends.

The logic of Chairman and founder Dan Kriznic is one that shareholders will certainly appreciate: “It made sense to give back [to those] who supported us.”

Not only have shareholders gotten dividends in an industry that generally hasn’t been mature enough to pay out—yet—but there’s a reason this company is a uniquely attractive entry point: Invictus MD’s market cap to funded capacity is about 5 times the industry standard.

Right now, the company has a funded production capacity of about 18,000 kilograms which, compared to its peers, suggests Invictus MD is significantly undervalued.

Its smart acquisitions have made all the difference.

Prior to October, when it entered the license producer market, Invictus MD was busy acquiring all the ‘picks and shovels’ of the cannabis space. Invictus MD has made one smart move after another, and it’s always the ‘pick and shovel’ guys who have real longevity. First, they acquired a fertilizer company that was cash-flow positive, and then they sold one of its lighting divisions for $5 million, having paid only $900,000 for it less than a year before.

They’ve been nurturing their shareholders along with their crops. Invictus MD’s focus on two verticals—cannabis cultivation and cannabis fertilizer and nutrients—gives it a competitive, low-cost advantage on this playing field.

Now they’ve got prime real estate to add to their portfolio, and this is one cash crop that should keep growing.

#4 ‘Top 40 under 40’ in Vancouver

There’s a reason this company is positioned for great things. Kriznic has been rated one of Business in Vancouver’s ‘Top 40 under 40’, and he’s put Invictus on the fast track to the market. He has built over a billion dollars in value for shareholders in his past. 

And not only are the strains pre-approved by the health authorities, but they will reach into every corner of this market. It’s a marijuana octopus that has left no stone unturned.

Those strains include high THC strains used to help with pain management and cancer, and high-CBD strains used for epilepsy and anxiety disorders. And when it comes to recreational—the company is gearing up to work on all strains available.

This combined with its tight capitalization structure and access to capital could make this a prime breakout target over the coming weeks and months.

They’re also not new to this game. Invictus MD isn’t just jumping on the green train at the 11th hour; it has been laying the ground work for a very smart expansion strategy.

Kriznic has turned $10-million companies into $150-million annual revenue generators. They’ve got a license to grow in more ways than one, and while they might not be a ‘green giant’ just yet, their undervaluation suggests they could be.

#5 Massive Demand Just Waiting to Be Legalized

The fundamentals are clear—demand is set to further explode once recreational use of cannabis becomes legal.

Where does this leave us with supply? Playing some serious catch-up, which is a producer’s dream. In Canada, legalizing recreational marijuana could result in demand of about 400,000 kilograms of cannabis in its first full year, according to Canaccord Genuity analysts. And that’s just for recreational use. Demand for medical cannabis is also growing at a significant pace, and the total combined demand for the first year could be 575,000 kilograms.

Source: New Frontier Data

Arcview Market Research of San-Francisco predicts that legal marijuana sales will reach close to $22 billion by 2021—up from nearly $7 billion last year. That’s an annual growth rate of 26 percent, and it’s in line with Deloitte’s own estimations.

In Canada alone, Canaccord Genuity predicts that the recreational marijuana industry could reach $6 billion in sales by 2021.

If you haven’t considered an entry point into this market yet—the window of opportunity is closing fast. Stocks are already shooting up on anticipation, and by 1 July 2018, high valuations will slam doors shut and only billionaires will come out. By that time, Invictus MD (TSX:IMH.V; OTC:IVITF) should already be walking with the green giants.

By James Burgess

Legal Disclaimer/Disclosure: This piece is an advertorial and has been paid for. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this Report should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. We make no guarantee, representation or warranty and accept no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of Oilprice.com only and are subject to change without notice. Oilprice.com assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this Report. All content contained herein is subject to the terms and conditions set forth in the original article posted on Oilprice.com and subject to the terms and conditions therein.

© 2017 Copyright OilPrice.com - All Rights Reserved
Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.

OilPrice.com Archive

© 2005-2017 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in

Catching a Falling Financial Knife